文献速递新生儿儿童呼吸儿童神经与发育行为

新生儿脑病治疗性低温中经皮二氧化碳监测的验证

Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in Neonates Undergoing Therapeutic Hypothermia for Neonatal Encephalopathy.
PubMed 文献 · J Pediatr · 2026-07-20

结果显示tcPCO2与各来源血气PCO2一致性中等且95%一致性界限宽,但可能有助于识别趋势和避免极端PCO2值。

要点

  • tcPCO2与温度校正PCO2的平均偏差为6.6 mm Hg,95%一致性界限为-7.4至+20.6 mm Hg。
  • 相对于实测PCO2,tcPCO2几何平均比值显示高估4%,比例95%一致性界限为-25%至+35%。
  • 毛细血管样本一致性随PCO2极端值变异增大(P < .05),而动脉和静脉样本偏差与方差稳定。

核心结论

  • 在新生儿脑病接受治疗性低温的婴儿中,tcPCO2与所有来源血气PCO2的一致性中等且95%一致性界限宽。

研究设计与样本

  • 研究纳入≥34周胎龄并接受治疗性低温的新生儿,连续监测tcPCO2,采用考虑配对重复测量的Bland-Altman分析评估tcPCO2与温度校正及实测血气PCO2的一致性。

主要发现

  • tcPCO2与所有来源温度校正PCO2的平均偏差为6.6 mm Hg,95%一致性界限为-7.4至+20.6 mm Hg。
  • 相对于实测PCO2,tcPCO2几何平均比值高估4%,比例95%一致性界限为-25%至+35%。
  • 毛细血管样本一致性随PCO2极端值变异显著增大(P < .05),动脉和静脉样本偏差与方差稳定。

临床怎么用

  • 尽管存在潜在偏差,tcPCO2可能有助于在治疗性低温期间识别PCO2趋势和避免极端PCO2值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the accuracy of transcutaneous carbon dioxide (tcPCO2) monitoring compared with intermittently sampled blood gas PCO2 in neonates undergoing therapeutic hypothermia (TH). STUDY DESIGN: Neonates ≥34 weeks of gestation undergoing TH were enrolled and subsequently monitored with continuous tcPCO2. Agreement between tcPCO2 and both temperature-corrected and measured (uncorrected) blood gas PCO2 from arterial, venous, and capillary sources was assessed using Bland-Altman analyses that accounted for paired repeated measures. RESULTS: One hundred thirty paired tcPCO2-PCO2 measurements were analyzed for 53 neonates. The mean difference (bias) between tcPCO2 and temperature-corrected PCO2 from all sources was 6.6 mm Hg with 95% limits of agreement from -7.4 to +20.6 mm Hg. Relative to measured PCO2, the geometric mean ratio indicated a 4% overestimation of tcPCO2, with proportional 95% limits of agreement from -25% to +35%. Capillary samples showed significant (P < .05) nonconstant variance in agreement with increasing variability at extreme PCO2 values, whereas arterial and venous samples demonstrated stable bias and variance across PCO2 ranges. CONCLUSIONS: Using transcutaneous CO2 monitoring in infants with neonatal encephalopathy receiving TH, there is moderate agreement with wide 95% limits of agreement between tcPCO2 and PCO2 from all sources. Despite potential bias, tcPCO2 may assist in identifying trends and avoiding extreme PCO2 values during TH. TRIAL REGISTRATION: https://clinicaltrials.gov/study/NCT04603547.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Hannon K, Szakmar E, Sunwoo J, et al. Validation of Continuous Transcutaneous Carbon Dioxide Monitoring in Neonates Undergoing Therapeutic Hypothermia for Neonatal Encephalopathy. J Pediatr. 2026. PMID: 42476296. doi:10.1016/j.jpeds.2026.115249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。